D70.1Billable

Agranulocytosis secondary to cancer chemotherapy

Chapter
3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Category
D70
Effective date
October 1, 2026

Related codes in category D70

D70NeutropeniaD70.0Congenital agranulocytosisYesD70.2Other drug-induced agranulocytosisYesD70.3Neutropenia due to infectionYesD70.4Cyclic neutropeniaYesD70.8Other neutropeniaYesD70.9Neutropenia, unspecifiedYes

Frequently asked questions

What is ICD-10 code D70.1?

D70.1 is an ICD-10-CM diagnosis code for Agranulocytosis secondary to cancer chemotherapy.

Is D70.1 a billable code?

Yes. D70.1 is billable and specific enough to be used on a claim.

What ICD-10-CM chapter is D70.1 in?

D70.1 falls under Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.

When did D70.1 become effective?

D70.1 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.

What other codes are related to D70.1?

D70.1 belongs to category D70, which includes 7 other codes — see the related codes list on this page.

ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.